Biological
Dendritic Cell Vaccine clinical trials
- studies test it
- 22
- open now
- 5
- in phase 3
- 1
- first study started
- 2001
Keep track of what changes. Save the Dendritic Cell Vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
22 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 3
- Phase 1
- 15
- Phase 2
- 6
- Phase 3
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 22
H. Lee Moffitt Cancer Center and Research Institute (5) · Federal University of São Paulo (2) · Oslo University Hospital (1) · Hasumi International Research Foundation (1) · Macarena De La Fuente, MD (1) · Baylor Research Institute (1) · Fundacion Clinic per a la Recerca Biomédica (1) · Hospital Clinic of Barcelona (1)
Often tested with
Tested in the same studies.
Maraviroc (2) · Dolutegravir (2) · Auranofin (2) · Niacinamide (2) · Trastuzumab (1) · Pepinemab (1)
Studies
Open first, then newest update. How each study uses Dendritic Cell Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 22
- Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without AntiretroviralsRecruitingPhase 2Federal University of São PauloNCT06805656Written as Dendritic Cell Vaccine
- Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant TherapyRecruitingEarly Phase 1H. Lee Moffitt Cancer Center and Research InstituteNCT06435351Written as Dendritic Cell (DC) Vaccine
- NEOadjuvant Dendritic Cell Vaccination for Ovarian CancerRecruitingPhase 1/2Radboud University Medical CenterNCT05773859Written as XP-DC vaccinations
- Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for GlioblastomaNot yet recruitingPhase 3University of Sao Paulo General HospitalNCT06749925Written as Dendritic Cell Vaccine
- T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With MelanomaRecruitingPhase 1Karolinska University HospitalNCT01946373Written as Dendritic cell vaccine
- HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast CancerCompletedEarly Phase 1H. Lee Moffitt Cancer Center and Research InstituteNCT03387553Written as Dendritic Cell Vaccine (DC1)
- A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)Active, not recruitingPhase 1H. Lee Moffitt Cancer Center and Research InstituteNCT05809752Written as Dendritic Cell Vaccine
- Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast CancerSuspendedPhase 1H. Lee Moffitt Cancer Center and Research InstituteNCT05378464Written as Dendritic Cell (DC1) Vaccine
- IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal MelanomaCompletedPhase 1Hasumi International Research FoundationNCT04335890Written as Vaccination with IKKb matured Dendritic Cells
- Vaccine Therapy in Curative Resected Prostate Cancer PatientsActive, not recruitingPhase 1/2Oslo University HospitalNCT01197625Written as Dendritic cell vaccine
- Dendritic Cell (DC) Vaccine for Malignant Glioma and GlioblastomaCompletedPhase 1Macarena De La Fuente, MDNCT01808820Written as Dendritic Cell Vaccine
- Dendritic Cell Vaccine for Head and Neck CancerWithdrawnPhase 1University of Maryland, BaltimoreNCT00492947Written as dendritic cell vaccine
- Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing CureCompletedNot applicableFederal University of São PauloNCT02961829Written as Dendritic Cell Vaccine
- A Combined Cell Therapy Approach to the Treatment of NeuroblastomaWithdrawnPhase 1H. Lee Moffitt Cancer Center and Research InstituteNCT02745756Written as KLH and Tumor Lysate Pulsed DC Vaccine
- Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)CompletedPhase 1Baylor Research InstituteNCT00796770Written as Dendritic Cell Vaccine
- Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast CancerStatus unknownEarly Phase 1Research Institute of Fundamental and Clinical ImmunologyNCT03113019Written as Immunotherapy based on dendritic cells
- Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain TumorsTerminatedPhase 1Edward ZigaNCT01902771Written as Dendritic Cell Vaccine
- Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal CancerCompletedPhase 2Fundacion Clinic per a la Recerca BiomédicaNCT01413295Written as Dendritic Cell Vaccine
- Dendritic Cell Vaccine in HIV-1 InfectionCompletedPhase 1/2Hospital Clinic of BarcelonaNCT00402142Written as Dendritic cell vaccine
- Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma PatientsCompletedPhase 1Cedars-Sinai Medical CenterNCT00576446Written as Dendritic cell Vaccine
See all 22 studies that test Dendritic Cell Vaccine →
Given in every arm · 4 — Dendritic Cell Vaccine is usual care beside what is tested
- Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMDRecruitingPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT07694986Written as cDC1 Vaccine
- Neoantigen Derived DCs as Cancer TreatmentRecruitingPhase 1National Health Research Institutes, TaiwanNCT05767684Written as Dendritic Cell Vaccine
- Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory LeukemiasWithdrawnPhase 1Juan C. Ramos, MDNCT05321940Written as Dendritic Cell Vaccine
- Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma MultiformeCompletedPhase 2Dartmouth-Hitchcock Medical CenterNCT00323115Written as Dendritic Cell Vaccine